CV-06

N/A

Report date: 2024/12/19 15:35:51

Base Information

Drug NameCV-06
Drug Alias NameCV-06iCP-Parkin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionE3 ubiquitin-protein ligase parkin stimulants
TargetsE3 ubiquitin-protein ligase parkin
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellivery Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellivery Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A